250 related articles for article (PubMed ID: 33165093)
41. Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma.
Horn LC; Höhn AK; Krücken I; Stiller M; Obeck U; Brambs CE
J Cancer Res Clin Oncol; 2020 Apr; 146(4):971-983. PubMed ID: 31927619
[TBL] [Abstract][Full Text] [Related]
42. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
43. Synchronous Bilateral Ovarian Mesonephric-like Adenocarcinomas with Separate Origins from High-Grade Mullerian Adenosarcoma and Endometriosis: Report of a Rare Case.
Zhao Z; Nadarajah R; Busmanis I
Int J Gynecol Pathol; 2024 Jul; 43(4):382-388. PubMed ID: 37922943
[TBL] [Abstract][Full Text] [Related]
44. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
Carleton C; Hoang L; Sah S; Kiyokawa T; Karamurzin YS; Talia KL; Park KJ; McCluggage WG
Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
[TBL] [Abstract][Full Text] [Related]
45. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
Euscher ED; Marques-Piubelli ML; Ramalingam P; Wistuba I; Lawson BC; Frumovitz M; Malpica A
Am J Surg Pathol; 2023 Jun; 47(6):635-648. PubMed ID: 37026792
[TBL] [Abstract][Full Text] [Related]
46. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Clinicopathological and Prognostic Significance of L1 Cell Adhesion Molecule (L1CAM) Over-expression.
Park S; Cho Y; Kim HS
Anticancer Res; 2023 Oct; 43(10):4559-4571. PubMed ID: 37772557
[TBL] [Abstract][Full Text] [Related]
47. Simultaneously detected endometrial and ovarian carcinomas--a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study.
Zaino R; Whitney C; Brady MF; DeGeest K; Burger RA; Buller RE
Gynecol Oncol; 2001 Nov; 83(2):355-62. PubMed ID: 11606097
[TBL] [Abstract][Full Text] [Related]
48. Mesonephric-like Adenocarcinoma of the Ovary: Clinicopathological and Molecular Characteristics.
Koh HH; Park E; Kim HS
Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204416
[TBL] [Abstract][Full Text] [Related]
49. Malignant mesonephric tumors of the female genital tract: a clinicopathologic study of 9 cases.
Bagué S; Rodríguez IM; Prat J
Am J Surg Pathol; 2004 May; 28(5):601-7. PubMed ID: 15105647
[TBL] [Abstract][Full Text] [Related]
50. Mesonephric-Like Carcinosarcoma of the Ovary Associated with Low-Grade Serous Carcinoma: A Case Report.
d'Amati A; Pezzuto F; Serio G; Marzullo A; Fortarezza F; Lettini T; Cazzato G; Cormio G; Resta L
Diagnostics (Basel); 2021 May; 11(5):. PubMed ID: 34063676
[TBL] [Abstract][Full Text] [Related]
51. Triple simultaneous primary invasive gynecological malignancies: a case report.
Takatori E; Shoji T; Miura Y; Takeuchi S; Uesugi N; Sugiyama T
J Obstet Gynaecol Res; 2014 Feb; 40(2):627-31. PubMed ID: 24147606
[TBL] [Abstract][Full Text] [Related]
52. Mesonephric-like adenocarcinoma of the female genital tract: possible role of KRAS-targeted treatment-detailed molecular analysis of a case series and review of the literature for targetable somatic KRAS-mutations.
Brambs CE; Horn LC; Hiller R; Krücken I; Braun C; Christmann C; Monecke A; Höhn AK
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15727-15736. PubMed ID: 37668797
[TBL] [Abstract][Full Text] [Related]
53. Pulmonary metastasis of mesonephric-like adenocarcinoma arising from the uterine body: a striking mimic of follicular thyroid carcinoma.
Yamamoto S; Sakai Y
Histopathology; 2019 Mar; 74(4):651-653. PubMed ID: 30471132
[No Abstract] [Full Text] [Related]
54. Mesonephric proliferations of the female genital tract.
Howitt BE; Nucci MR
Pathology; 2018 Feb; 50(2):141-150. PubMed ID: 29269124
[TBL] [Abstract][Full Text] [Related]
55. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
[TBL] [Abstract][Full Text] [Related]
56. Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma.
Torenbeek R; Lagendijk JH; Van Diest PJ; Bril H; van de Molengraft FJ; Meijer CJ
Histopathology; 1998 Jan; 32(1):20-7. PubMed ID: 9522212
[TBL] [Abstract][Full Text] [Related]
57. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
58. Four synchronous female genital malignancies: the ovary, cervix, endometrium and fallopian tube.
Saglam A; Bozdag G; Kuzey GM; Kuçukali T; Ayhan A
Arch Gynecol Obstet; 2008 Jun; 277(6):557-62. PubMed ID: 18066567
[TBL] [Abstract][Full Text] [Related]
59. Mesonephric adenocarcinoma of the cervix: a case report with a three-year follow-up, lung metastases, and next-generation sequencing analysis.
Montalvo N; Redrobán L; Galarza D
Diagn Pathol; 2019 Jul; 14(1):71. PubMed ID: 31266530
[TBL] [Abstract][Full Text] [Related]
60. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas.
Siami K; McCluggage WG; Ordonez NG; Euscher ED; Malpica A; Sneige N; Silva EG; Deavers MT
Am J Surg Pathol; 2007 Nov; 31(11):1759-63. PubMed ID: 18059234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
